Liminatus Pharma, Inc. (LIMN) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$9.81M | +49.3% |
| 2024 | -$19.34M | -22.5% |
| 2023 | -$15.79M | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | -$9.81M | +49.3% |
| 2024 | -$19.34M | -22.5% |
| 2023 | -$15.79M | — |